These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20620306)

  • 1. Correlation between prenatal urinary matrix metalloproteinase activity and the degree of kidney damage in a large animal model of congenital obstructive uropathy.
    Nicksa GA; O'Neil E; Yu DC; Curatolo AS; McNeish BL; Barnewolt CE; Zurakowski D; Buchmiller TL; Moses MA; Rosen S; Fauza DO
    J Pediatr Surg; 2010 Jun; 45(6):1120-5. PubMed ID: 20620306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal urinary matrix metalloproteinase profiling as a potential diagnostic tool in fetal obstructive uropathy.
    Nicksa GA; Yu DC; Curatolo AS; McNeish BL; Barnewolt CE; Valim C; Buchmiller TL; Moses MA; Fauza DO
    J Pediatr Surg; 2010 Jan; 45(1):70-3. PubMed ID: 20105582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical implications of urine matrix metalloproteinases and their inhibitors in patients with chronic glomerulonephritis].
    Li OA; Bobkova IN; Kozlovckaia LV
    Ter Arkh; 2009; 81(8):10-4. PubMed ID: 19799193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex.
    Iimura O; Takahashi H; Yashiro T; Madoiwa S; Sakata Y; Asano Y; Kusano E
    Clin Exp Nephrol; 2004 Sep; 8(3):223-9. PubMed ID: 15480899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of congenital obstructive nephropathy: past, present and future.
    Chevalier RL
    J Urol; 2004 Sep; 172(3):852-7. PubMed ID: 15310982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine.
    Eissa S; Ali-Labib R; Swellam M; Bassiony M; Tash F; El-Zayat TM
    Eur Urol; 2007 Nov; 52(5):1388-96. PubMed ID: 17466450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.
    Devlieger R; Riley SC; Verbist L; Leask R; Pijnenborg R; Deprest JA
    J Soc Gynecol Investig; 2002; 9(3):137-45. PubMed ID: 12009387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
    J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
    Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
    Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
    Sier CF; Casetta G; Verheijen JH; Tizzani A; Agape V; Kos J; Blasi F; Hanemaaijer R
    Clin Cancer Res; 2000 Jun; 6(6):2333-40. PubMed ID: 10873084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell growth regulated genes in the fetal kidney: relevance to in utero obstruction.
    Carr MC; Schlussel RN; Peters CA; Uchida T; Mandell J; Freeman MR
    J Urol; 1995 Jul; 154(1):242-6. PubMed ID: 7776438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of fetal ovine renal dysplasia after mid-gestation ureteral obstruction.
    Matsell DG; Bennett T; Bocking AD
    Clin Invest Med; 1996 Dec; 19(6):444-52. PubMed ID: 8959354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine.
    Babjuk M
    Eur Urol; 2007 Nov; 52(5):1396-7. PubMed ID: 17466449
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental congenital obstructive uropathy.
    Peters CA; Mandell J
    Urol Clin North Am; 1990 May; 17(2):437-47. PubMed ID: 2186545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors.
    Di Carlo A; Terracciano D; Mariano A; Macchia V
    Oncol Rep; 2006 May; 15(5):1321-6. PubMed ID: 16596205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.
    Durkan GC; Nutt JE; Marsh C; Rajjayabun PH; Robinson MC; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2003 Jul; 9(7):2576-82. PubMed ID: 12855633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.